A review of the use of psychotropic medication to address challenging behaviour in neurodevelopmental disorders.

Engagement in challenging behaviour (e.g., aggression, self-injury) is reported to occur in neurodevelopmental disorders such as intellectual disabilities (ID), autism spectrum disorder (ASD), and fragile X syndrome (FXS).